A Community Collaboration Between IU Health and St. Vincent
Current Studies & Research
Rehabilitation Hospital of Indiana Research Participant Registry

James Malec, Ph.D. – Principal Investigator The purpose of RHI’s Research Participant Registry is to create a RHI Research Participant Registry of individuals who are interested in participating or who… Read More

IU InterFACE Center at Rehabilitation Hospital of Indiana

The IU Interactive and Functional Assessment of Communication and Emotion Center is a natural observation laboratory designed to research emotional and behavioral deficits in people with neurological, psychological, and developmental… Read More

Resource Facilitation-Best Practices Manual for Return to Work/School

Resource Facilitation: Indiana Best Practices Manual for Return-to- Work or Return-to-School     Click on the read more button to get a link to download the full manual.  Once you… Read More

Multicenter Evaluation of Memory Remediation after TBI with Donepezil (MEMRI-TBI-D Study)

Multicenter Evaluation of Memory Remediation after TBI with Donepezil (MEMRI-TBI-D Study) March 10, 2015 Flora Hammond, MD (PI); Funded by National Institute on Disability and Rehabilitation Research (NIDRR).  This study… Read More

Brain Injury Association of America ~ The Challenge

Flora M. Hammond, M.D. is featured as one of the TBI Model Systems Researchers in the Fall Edition of the Brain Injury Association of America ‘The Challenge’ Publication. Click on… Read More

SEE ALL RESEARCH
BACK
Post-TBI Irritability & Aggression: Building Evidence-Based Approaches to Management April 26th, 2013

       Flora Hammond, MD (PI), James Malec, PhD (Co-PI), Jacob Kean, PhD, Susan Perkins, PhD, Patrick Monahan, PhD, funded by National Institute on Disability and Rehabilitation Research (NIDRR).

 

  • Treatment and Placebo Arm: “Buspirone for the Treatment of Chronic Post-TBI Irritability and Aggression: A 91-Day Single- Site, Flexible-Dose, Parallel Group, Randomized, Placebo-Controlled Trial”
  • Measurement Arm: “Preliminary Development of the Aggression and Irritability Impact Measure”

 

PURPOSE OF PROJECT: To study the effect expressed by persons with TBI through assessment of buspirone effectiveness for post-traumatic irritability and aggression and development of an irritability/aggression impact measure.

 

SUMMARY OF PROJECT: It is anticipated that 74 subjects with 74 corresponding subject observers will be recruited for the treatment study. Subjects will be recruited from community and self-referrals.

 

Contact Person:  Becky Runkel, at becky.runkel@rhin.com , or at (317) 329-2217.